Yuchuan Jiang

629 total citations
20 papers, 224 citations indexed

About

Yuchuan Jiang is a scholar working on Pathology and Forensic Medicine, Hepatology and Molecular Biology. According to data from OpenAlex, Yuchuan Jiang has authored 20 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Yuchuan Jiang's work include Cancer Mechanisms and Therapy (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver physiology and pathology (4 papers). Yuchuan Jiang is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver physiology and pathology (4 papers). Yuchuan Jiang collaborates with scholars based in China and United States. Yuchuan Jiang's co-authors include Jian Hong, Chen Qu, Wenyu Lin, Mingrong Cao, Lu He, Jinying Li, Hui Yuan, Shuang Peng, Kaishun Hu and Dandan Zheng and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Oncogene.

In The Last Decade

Yuchuan Jiang

17 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuchuan Jiang China 9 85 58 49 47 45 20 224
Yiming Lei China 8 174 2.0× 119 2.1× 37 0.8× 65 1.4× 42 0.9× 15 293
David Agdashian United States 4 74 0.9× 37 0.6× 86 1.8× 37 0.8× 201 4.5× 6 343
Marcell Tóth Germany 7 134 1.6× 41 0.7× 22 0.4× 21 0.4× 48 1.1× 15 225
Na‐Lee Ka South Korea 10 159 1.9× 68 1.2× 12 0.2× 73 1.6× 88 2.0× 14 308
Yunfei Duan China 12 198 2.3× 149 2.6× 39 0.8× 50 1.1× 49 1.1× 17 350
Sandra Schmidhofer Germany 8 233 2.7× 29 0.5× 27 0.6× 110 2.3× 40 0.9× 9 412
Sharon De Morrow United States 3 41 0.5× 26 0.4× 96 2.0× 37 0.8× 64 1.4× 3 249
Shumin Ma China 11 202 2.4× 21 0.4× 28 0.6× 70 1.5× 39 0.9× 32 292
Maoying Han China 6 116 1.4× 25 0.4× 69 1.4× 36 0.8× 21 0.5× 11 266
Guifang Gan China 6 105 1.2× 74 1.3× 6 0.1× 25 0.5× 100 2.2× 9 226

Countries citing papers authored by Yuchuan Jiang

Since Specialization
Citations

This map shows the geographic impact of Yuchuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchuan Jiang more than expected).

Fields of papers citing papers by Yuchuan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuchuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchuan Jiang. The network helps show where Yuchuan Jiang may publish in the future.

Co-authorship network of co-authors of Yuchuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuchuan Jiang. A scholar is included among the top collaborators of Yuchuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuchuan Jiang. Yuchuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Kai, et al.. (2025). Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications. Frontiers in Immunology. 16. 1723346–1723346.
2.
Lin, Junhao, Yuchuan Jiang, Xinhui Liu, et al.. (2025). Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway. Frontiers in Oncology. 14. 1517226–1517226.
3.
Zheng, Dandan, Mingrong Cao, Qiang Li, et al.. (2025). Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS. Frontiers in Oncology. 15. 1570029–1570029. 1 indexed citations
4.
Chen, Fangfang, Haili Cheng, Ting Xu, et al.. (2025). Hepatocellular carcinoma escapes immune surveillance through deceiving thymus into recalling peripheral activated CD8+ T cells. Neoplasia. 67. 101210–101210. 1 indexed citations
5.
Shao, Yue, Junling Chen, Jiayue Yang, et al.. (2025). The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination. Experimental & Molecular Medicine. 57(10). 2317–2330.
6.
Yao, Nan, Bo Deng, Jinying Li, et al.. (2024). GINS1 promotes ZEB1‐mediated epithelial‐mesenchymal transition and tumor metastasis via β‐catenin signaling in hepatocellular carcinoma. Journal of Cellular Physiology. 239(5). e31237–e31237. 8 indexed citations
7.
Li, Qiang, Xiaolan Wang, Quan Jiang, et al.. (2024). Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma. Journal of Visualized Experiments. 1 indexed citations
8.
Zhang, Di, Yang Xiao, Hui Yuan, et al.. (2023). Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin. Oncogene. 42(18). 1492–1507. 10 indexed citations
9.
Liang, Junjie, Quan Jiang, Leyang Xiang, et al.. (2023). Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma. Journal of Visualized Experiments. 3 indexed citations
10.
Lai, Tianqi, Jinying Li, Yuchuan Jiang, et al.. (2023). A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. Translational Cancer Research. 12(5). 1145–1164. 5 indexed citations
11.
Liang, Junjie, Jiexing Li, Yuchuan Jiang, et al.. (2023). Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery. Journal of Visualized Experiments. 2 indexed citations
12.
13.
14.
Jiang, Yuchuan, Siliang Chen, Qiang Li, et al.. (2021). TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration. Frontiers in Immunology. 12. 612139–612139. 31 indexed citations
15.
Jiang, Yuchuan, Peng Chen, Kaishun Hu, et al.. (2021). Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation. Journal of Cellular and Molecular Medicine. 25(3). 1568–1582. 28 indexed citations
16.
Qu, Chen, Lu He, Nan Yao, et al.. (2021). Myofibroblast‐Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model. Hepatology. 74(1). 458–473. 20 indexed citations
17.
Luo, Xiaojun, Yuchuan Jiang, Yue Luo, et al.. (2020). Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation. Experimental & Molecular Medicine. 52(7). 1062–1074. 34 indexed citations
18.
Zheng, Dandan, Yuchuan Jiang, Chen Qu, et al.. (2020). Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. American Journal Of Pathology. 190(11). 2267–2281. 50 indexed citations
19.
Yang, Ping, Yuchuan Jiang, Pengzhi Hong, & Wenhong Cao. (2013). Angiotensin I converting enzyme inhibitory activity and antihypertensive effect in spontaneously hypertensive rats of cobia (Rachycentron canadum) head papain hydrolysate. Food Science and Technology International. 19(3). 209–215. 5 indexed citations
20.
He, Xiaowei, et al.. (2010). Sparse Regularization-Based Reconstruction for Bioluminescence Tomography Using a Multilevel Adaptive Finite Element Method. International Journal of Biomedical Imaging. 2011. 1–11. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiming Lei Breakdown of academic impact, for papers by David Agdashian Breakdown of academic impact, for papers by Marcell Tóth Breakdown of academic impact, for papers by Na‐Lee Ka Breakdown of academic impact, for papers by Yunfei Duan Breakdown of academic impact, for papers by Sandra Schmidhofer Breakdown of academic impact, for papers by Sharon De Morrow Breakdown of academic impact, for papers by Shumin Ma Breakdown of academic impact, for papers by Maoying Han Breakdown of academic impact, for papers by Guifang Gan
Rankless by CCL
2026